



Betaproteobacteria are predominant in drinking water: are there reasons 1 
for concern? 2 
 3 
Abstract  4 
Betaproteobacteria include some of the most abundant and ubiquitous bacterial genera that 5 
can be found in drinking water, including mineral water. The combination of physiology and 6 
ecology traits place some Betaproteobacteria in the list of potential, yet sometimes neglected, 7 
opportunistic pathogens that can be transmitted by water or aqueous solutions. Indeed, some 8 
drinking water Betaproteobacteria with intrinsic and sometimes acquired antibiotic 9 
resistance, harboring virulence factors and often found in biofilm structures, can persist after 10 
water disinfection and reach the consumer. 11 
This literature review summarizes and discusses the current knowledge about the occurrence 12 
and implications of Betaproteobacteria in drinking water. Although the sparse knowledge 13 
on the ecology and physiology of Betaproteobacteria thriving in tap or bottled natural 14 
mineral/spring drinking water (DW) is an evidence of this review, it is demonstrated that DW 15 
holds a high diversity of Betaproteobacteria, whose presence may not be innocuous. 16 
Frequently belonging to genera also found in humans, DW Betaproteobacteria are ubiquitous 17 
in different habitats, have the potential to resist antibiotics either due to intrinsic or acquired 18 
mechanisms, and hold different virulence factors. The combination of these factors place DW 19 
Betaproteobacteria in the list of candidates of emerging opportunistic pathogens. Improved 20 




additional genomic and physiological studies may contribute to elucidate the potential impact 22 
of these bacteria.  23 
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The access to safe drinking water (DW) is defined as one of the Sustainable Development 31 
Goals and an important human right 32 
(https://www.un.org/sustainabledevelopment/sustainable-development-goals/). By 33 
definition, DW is suitable for human consumption, washing/showering and domestic food 34 
preparation (EuropeanComission 1998; Bartram et al. 2003; WHO 2011). DW comprises i) 35 
tap water originating from a surface water (river, lagoons, alluvial wells) or groundwater 36 
source that, when necessary may be subjected to treatment before distribution to the 37 
consumer, and ii) the bottled natural mineral or spring water originating from a groundwater 38 
table or deposit that emerges from a spring or borehole exit (Barrell et al. 2000). While the 39 
so-called tap-water needs treatment in most world regions, due to the widespread 40 
contamination of water sources, the natural mineral or spring water is “microbiologically 41 
wholesome” and must not receive any treatment capable of changing the original chemical 42 
and microbiological composition (EuropeanComission 2009). Mineral and spring waters are 43 
commonly bottled before distribution to the consumer. 44 
The natural mineral and spring waters microbiomes comprise the autochthonous bacterial 45 
community, although the structure of that bacterial community may change after bottling and 46 
storage (Flemming et al. 2016). Otherwise, the tap water microbiome occurring in the water 47 
that reaches the consumer does not necessarily mirror that thriving in the water source. This 48 
is due to the successive alterations that take place from the source to the tap, shaped mainly 49 
by a complex interplay between treatment, reactivation, and piping (Norton and LeChevallier 50 
2000; Hoefel et al. 2005; Eichler et al. 2006; Lautenschlager et al. 2010; Vaz-Moreira et al. 51 




the persistence of some autochthonous bacterial community members that survive the 53 
treatment (e.g. chlorination, ozonation or UV irradiation), together with potential intrusions 54 
of bacteria throughout the system from the source to the tap. The properties of water and 55 
specific physicochemical factors, such as total organic content or hydrodynamic regime, the 56 
conditions of the pipes, the range of temperature and pH, the residence time, among others, 57 
may influence the shape of the bacterial community (Pepper et al. 2004; Lautenschlager et 58 
al. 2010; Pinto et al. 2012; Douterelo et al. 2013; Lautenschlager et al. 2014). Another 59 
important driver of the tap water bacterial community composition and structure is the 60 
formation of biofilms along the distribution systems, which may rule the release of biofilm 61 
bacteria into the circulating water (Batté et al. 2003). Despite the specificities of each water 62 
source, piping and treatment conditions, Proteobacteria (mainly of the classes Alpha, Beta 63 
and Gamma) are among the predominant populations in DW, tap or mineral/spring, 64 
worldwide (Leclerc and Moreau 2002; Hoefel et al. 2005; Loy et al. 2005; Eichler et al. 2006; 65 
Poitelon et al. 2009; Revetta et al. 2010; Pinto et al. 2012; Vaz-Moreira et al. 2014). Dias et 66 
al. (2019) recently described that the Proteobacteria profile changes from the distribution 67 
system to tap water, with Alphaproteobacteria being dominant in the distribution system 68 
(92% vs. 65% in tap waters), whereas Betaproteobacteria prevalence in tap water was higher 69 
than in the distribution system (18% vs. 2%). This variation was attributed to the higher 70 
chlorine tolerance observed in members of the class Alphaproteobacteria when compared to 71 
members of the class Betaproteobacteria (Williams et al. 2004; McCoy and VanBriesen 72 
2012; Dias VCF et al. 2019). 73 
Although water Alphaproteobacteria, and mainly Gammaproteobacteria, that include some 74 




Gammaproteobacteria Legionella, Escherichia coli, Vibrio spp., Salmonella, Acinetobacter 76 
baumannii and Klebsiella pneumoniae) have been frequently discussed, Betaproteobacteria 77 
are, comparatively, a neglected group. This gap of information was a major motivation to 78 
bring forward the current review, focused on DW Betaproteobacteria.  79 
DW is an important source for the dissemination and transmission of microbial agents to 80 
humans, meaning that the DW microbiome may pose important potential risks for human 81 
health. In a previous study, Vaz-Moreira and colleagues (2017) observed that Proteobacteria 82 
genera can persist after DW treatment, being ubiquitous along the DW source-treatment-83 
distribution-tap thread. In that study, the ubiquity of Betaproteobacteria in the DW system 84 
was evidenced, confirming previous studies conducted in other clean environments, such as 85 
filtered water, antiseptics or disinfectants (Hahn 2004; Weber et al. 2007). These results are 86 
also in line with data reported in studies about bottled natural mineral water, which identify 87 
Betaproteobacteria among the predominant bacterial groups (Leclerc and Moreau 2002; Loy 88 
et al. 2005; França et al. 2015). The remarkable capacity to form biofilm in freshwater 89 
habitats (Manz et al. 1999; Araya et al. 2003) and the survival to disinfectants and 90 
disinfection processes (Mi et al. 2015; Becerra-Castro et al. 2016) are probably part of the 91 
explanation for the observed ubiquity of Betaproteobacteria in DW. These evidences claim 92 
for the attention of the scientific community mainly because some of the DW 93 
Betaproteobacteria genera may comprise opportunistic pathogens and/or drug resistant 94 
bacteria. In this review, we were interested in overviewing what is known about 95 
Betaproteobacteria ecology, intrinsic or acquired antibiotic resistance and virulence factors, 96 
as background information for discussing potential human health implications and, if 97 





Context and approach 100 
Based mainly on phylogenetic evidence, recently Parks et al. (2018) proposed that the class 101 
Betaproteobacteria would be better reclassified into the order Betaproteobacteriales, within 102 
the class Gammaproteobacteria. For practical reasons, this review followed the NCBI 103 
Taxonomy database (https://www.ncbi.nlm.nih.gov/Taxonomy/), in which the class 104 
Betaproteobacteria comprises 23 families and a large group of unclassified 105 
Betaproteobacteria, including some groups with Candidatus statute (accessed in 106 
https://www.ncbi.nlm.nih.gov/Taxonomy/ in August 2019). Most of these 23 families (17) 107 
have been reported in DW habitats (Figure 1). This is not surprising, given the ubiquity of 108 
Betaproteobacteria, whose colonized habitats include soil and rhizosphere, plants, foods, 109 
clinical samples, among other (Garrity et al. 2005), as well as aquatic environments, 110 
particularly DW (Leclerc and Moreau 2002; Hoefel et al. 2005; Loy et al. 2005; Eichler et 111 
al. 2006; Poitelon et al. 2009; Revetta et al. 2010; Pinto et al. 2012; Vaz-Moreira et al. 2014).  112 
For this review were selected studies that approach the bacterial diversity in water destined 113 
for human consumption, both treated tap water and bottled natural mineral/spring water. This 114 
selection included also the bacterial diversity of treated drinking water biofilms, since 115 
biofilms are known to strongly influence and result from the tap water bacterial diversity 116 
(Berry et al. 2006; Srinivasan et al. 2008). For the review were selected papers published 117 
after 1998, most of which based on culture-independent methods, although some relied also 118 
on culture-dependent methods. Were excluded the studies in which bacterial identification 119 




from a transient or resident bacterial colonization, we also explored if the Betaproteobacteria 121 
genera detected in DW have been reported in the human microbiome. These analyses were 122 
based on the Human Microbiome (https://hmpdacc.org/catalog/) and Human Oral 123 
microbiome (http://www.homd.org/) catalogs, and the NCBI database 124 
(www.ncbi.nlm.nih.gov) filtering by “Host: Homo sapiens”, accessed in June 2018. Our 125 
rationale was that closely related bacteria, as are the members of the same genera or species, 126 
tend to share an important part of the core genome, including housekeeping functions that 127 
may also serve for colonization and infection in a host (Wu HJ et al. 2008; Linz et al. 2016; 128 
Wu Y et al. 2018). In contrast, the gain or loss of some functions and genes may be part of 129 
the adaptation process to a given environment and may be the basis of the speciation 130 
transformation (Lawrence 2002). In this process, it is observed that some traits may be even 131 
strain specific (Bentley 2009; D'Auria et al. 2010). However, the demonstration that in a 132 
given bacterial group some traits can be observed, is a good indication of the potential 133 
occurrence in the whole species or genus. This is particularly relevant in ubiquitous bacterial 134 
groups, the focus of this review, in which adaptation and speciation may be hindered or at 135 
least shaped by a permanently changing environment. 136 
The filters used led to a list of 24 Betaproteobacteria genera that were detected both in tap 137 
and bottled natural mineral/spring water and whose association with humans was also 138 
reported. Members of these genera were examined for their potential as 139 
carriers/disseminators of virulence or of antimicrobial resistance determinants. The virulence 140 
factors were compiled from the literature available and from the Virulence Factors Database 141 
(VFDB, http://www.mgc.ac.cn/VFs/), accessed in July 2018. Intrinsic and acquired 142 





Betaproteobacteria in drinking water 145 
As mentioned above, a total of 17 Betaproteobacteria families, belonging to six orders, were 146 
reported in DW habitats. The most commonly reported families (Comamonadaceae, 147 
Oxalobacteraceae, Burkholderiaceae, Alcaligenaceae, and unclassified Burkholderiales), 148 
represented by 54 out of 83 genera, belong to the order Burkholderiales (Figure 1). A total 149 
of 63 bacterial genera were identified in bottled natural mineral/spring water and 55 in tap  150 
DW. Among those, 36 genera were reported in both mineral/spring and tap DW. These 151 
bacteria were members of 5 of the 6 orders of Betaproteobacteria described in DW: 152 
Burkholderiales (25 genera), Rhodocyclales (5 genera), Neisseriales (2 genera), 153 
Nitrosomonadales (2 genera), Hydrogenophilales (1 genus), and Methylophilales (1 genus) 154 
(Figure 1). This distribution suggests the endemic character of bacteria of these orders to 155 
DW, independently of being tap or bottled mineral/spring water. In contrast, some 156 
Betaproteobacteria were only reported in bottled mineral water habitats, and, to our 157 
knowledge, were never reported in treated tap DW (e.g. Pseudorhodoferax, Brachymonas, 158 
Ottowia, Caenimonas, Alicycliphilus, Ramlibacter, Diaphorobacter, Xenophilus, Xylophilus, 159 
Leptothrix, Piscinibacter, Tepidimonas, Oxalobacter, Telluria, Paucimonas, Derxia, 160 
Alcaligenes, Methylobacillus, Sulfuritalea, Azoarcus, Deefgea, and Ferritrophicum) (Figure 161 
1). This may suggest the influence of physiologic and metabolic properties of these bacteria 162 
and/or their susceptibility to water treatment.  163 
As expected, most of the bacterial genera observed in treated DW biofilms were also 164 




Undibacterium, Neisseria, Methylibium, Methylotenera, and Methylovorus. Most of the 166 
genera observed to be ubiquitous in DW were also reported in association with humans (24 167 
out of the 36: Achromobacter, Ralstonia, Limnobacter, Burkholderia, Cupriavidus, 168 
Acidovorax, Delftia, Polaromonas, Curvibacter, Variovorax, Comamonas, Pelomonas, 169 
Malikia, Herminiimonas, Janthinobacterium, Herbaspirillum, Massilia, Aquabacterium, 170 
Ideonella, Chromobacterium, Methylophilus, Dechloromonas, Propionivibrio, and 171 
Azospira) (Figure 1). Members of these genera represent candidates for possible interaction 172 
with the human microbiome, leading to the eventual resident colonization or transfer of 173 
acquired traits, such as virulence or resistance to antibiotics. However, the possible risks to 174 
human health are obviously dose dependent, and therefore any risk discussion should rely 175 
also on quantitative analyses rather than only on qualitative diversity assessments. However, 176 
the use of diverse sampling and analyses methods in the supporting literature seriously limit 177 
the possibility of doing accurate quantitative comparisons. Not much is known about the 178 
influence of DW bacteria in the human gut and in what conditions DW bacteria can represent 179 
a risk for human health. The importance of DW as a vehicle of Betaproteobacteria was 180 
highlighted by Lee et al. (2010), who used germ-free mice to demonstrate a correlation 181 
between the bacterial communities originating in the DW and those present in the 182 
gastrointestinal tract, with the Betaproteobacteria Ralstonia representing one of the bacterial 183 
genera transported to the gastrointestinal tract via DW. Recently, Dias et al. (2018) studied 184 
the response of the mouse gut bacterial community to the ingestion of different types of DW. 185 
After 23 days of water consumption, it was observed a significant increase in feces of the 186 
relative abundance of Firmicutes for the different types of water, and of Acinetobacter and 187 





Survival strategies 190 
Betaproteobacteria comprise bacteria with the capacity to survive disinfectants or 191 
disinfection processes (Williams et al. 2004; Garrity et al. 2005; Mi et al. 2015), which 192 
facilitate the persistence of these bacteria in DW treatment systems. Although the 193 
mechanisms responsible for this increased survival capacity are not fully understood, they 194 
are supposed to result from the complex interplay of different physiological and structural 195 
properties, such as the oligotrophic and auxotrophic character, detoxification, efficient stress 196 
responses or charity mechanisms among community members (Chapman 2003; Davin-Regli 197 
and Pages 2012; Mi et al. 2015). For example, detoxification is hinted by the capacity of 198 
some Betaproteobacteria (e.g. Burkholderia cepacia, Ralstonia spp., and Delftia spp.) to 199 
biodegrade disinfection byproducts (Field and Sierra-Alvarez 2004; Miyake-Nakayama et al. 200 
2006; Bull et al. 2011). These properties may explain the Betaproteobacteria dominance in 201 
treated DW, and their fitness to survive the water treatment, becoming the largest 202 
proteobacterial class in treated water and associated biofilms (Kalmbach et al. 2000; Mi et 203 
al. 2015). In a study aiming to identify the microorganisms and genes involved in the 204 
biodegradation of benzalkonium chlorides and quaternary ammonium compounds, Ertekin 205 
et al. (2016) highlighted the capacity of Proteobacteria, with Achromobacter spp. (members 206 
of the class Betaproteobacteria) among the most abundant species, to survive and degrade 207 
benzalkonium chlorides. Interestingly, such a capacity was associated with multidrug 208 
resistance (mainly multidrug resistance efflux proteins), oxidative stress response (e.g. 209 
glutathione S-transferases), gene expression regulation (e.g. members of the LysR, LysE, 210 




(mainly dehydrogenases and FAD dependent oxidoreductases), protein metabolism, outer 212 
cell structure modification, and transport (Ertekin et al. 2016; Duangurai et al. 2018). The 213 
exposure to sub-inhibitory concentrations of quaternary ammonium compounds, as well as 214 
to other antimicrobials, creates (oxidative) stress. The response to that stress may boost gene 215 
transfer and recombination events via prophages, transposons, integrons and integrative-216 
conjugative elements (ICEs) (Tezel and Pavlostathis 2015). Those mobile genetic elements 217 
are frequently described in Betaproteobacteria (Riccio et al. 2001; Shin et al. 2005; Ryan et 218 
al. 2009; Rhodes and Schweizer 2016). These mechanisms have also implications in the 219 
microbial community charity. In addition, the oligotrophic and/or auxotrophic character, as 220 
well as, the efficient stress response of some of these bacteria are related with the resilience 221 
of Betaproteobacteria, demonstrated to occur as contaminants of sterile solutions or of 222 
disinfectant solutions (Weber et al. 2007). For example, Ralstonia spp. are often reported as 223 
contaminants in blood culture medium, sterile saline solution or other medical solutions 224 
(Gardner and Shulman 1984; McNeil et al. 1985; Roberts et al. 1990; Lacey and Want 1991; 225 
Maki et al. 1991; Luk 1996; Labarca et al. 1999; Maroye et al. 2000; Boutros et al. 2002; 226 
Gröbner et al. 2007). Also, Burkholderia spp. (Magalhaes et al. 2003; Doit et al. 2004; Nasser 227 
et al. 2004; Estivariz et al. 2006; Held et al. 2006; Ko et al. 2015), and Achromobacter spp. 228 
(Vu-Thien et al. 1998; Tena et al. 2005; Turgutalp et al. 2012; Hugon et al. 2015) have been 229 
reported as contaminants of disinfectants solutions and medications. This capacity to survive 230 
disinfectants or disinfection processes may explain the high diversity of Betaproteobacteria 231 
observed in treated tap water (Figure 1).  232 
Associated with the capacity to survive treatment processes (e.g. disinfectants, toxic metals, 233 




and O'Toole 2001; Emtiazi et al. 2004; Schwering et al. 2013; Ertekin et al. 2016; Flemming 235 
et al. 2016; Ferro et al. 2019). The association between both characteristics may have two 236 
explanations: i) the bacteria with increased fitness to survive antimicrobial agents are those 237 
able to form or incorporate biofilm structures, or ii) the biofilm provides an increased 238 
protection against external attacks (e.g. disinfectants) working as a kind of shield by 239 
inhibiting the antimicrobial diffusion by the extracellular polymeric substance (EPS) 240 
molecules or by a direct consequence of the slow growth state of the biofilm cells avoiding 241 
drugs that target metabolic processes occurring during growth (Lewis 2001; Berry et al. 2006; 242 
Anderson and O'Toole 2008; Dufour et al. 2010; Schwering et al. 2013; Flemming et al. 243 
2016). Indeed, both mechanisms are probably combined, as is reported for example for 244 
Ralstonia pickettii, able to survive disinfectant solutions and form biofilm in industrial and 245 
pharmaceutical high-purity water systems (Kulakov et al. 2002; Adley et al. 2005; Ryan et 246 
al. 2011). In DW, it was observed that most of the bacterial genera reported in biofilms were 247 
also reported in tap water (e.g. Ralstonia, Limnobacter, Burkholderia, Cupriavidus, 248 
Acidovorax, Delftia, Polaromonas, Curvibacter, Variovorax, Janthinobacterium, 249 
Herbaspirillum, Aquabacterium, Dechloromonas), suggesting that these bacteria exist in a 250 
dynamic equilibrium between the planktonic and biofilm state. However, some genera, 251 
described mainly in biofilms rather than in the planktonic state in DW, such as Sutterella, 252 
Undibacterium, Neisseria, Methylibium, Methylotenera, and Methylovorus, may benefit 253 
from the protective biofilm structure (Figure 1). That protective effect was demonstrated for 254 
instance in Neisseria gonorrhoeae observed to be more resistant to non-thermal atmospheric 255 
pressure plasma treatment in the biofilm-resident state than in the planktonic form (Xu et al. 256 
2011). Also UV disinfection may enhance the biofilm metabolic activity (Schwartz et al. 257 




Other mechanisms, such as the association with free-living amoebas, may also explain the 259 
good fitness of the Betaproteobacteria in DW. The free-living amoebas can easily resist the 260 
DW treatment and are important in the bacterial community modulation since they feed on 261 
bacteria, by phagocytosis (Delafont et al. 2016). However, some bacteria developed 262 
mechanisms of amoeba-digestion resistance, and instead of dying when internalized by 263 
amoeba, they survive and multiply, being later released back to the environment. Among the 264 
bacterial characteristics described as relevant for their increased survival to amoeba grazing 265 
are features as the cell surface properties, the production of bioactive metabolites, the 266 
swimming speed, the microcolony formation or the cell-to-cell communication (Matz and 267 
Kjelleberg 2005). As happens with other taxa, Betaproteobacteria comprise amoeba-268 
resistant members, as for example the genera Achromobacter, Burkholderia, 269 
Chromobacterium, Delftia, and Ralstonia (Thomas et al. 2010). Curiously, all of these genera 270 
have been reported in both tap and bottled mineral DW as well as in the human microbiome 271 
(Figure 1). 272 
 273 
 274 
DW Betaproteobacteria as potential carriers of virulence factors  275 
Virulence factors are molecules that enable a microorganism to establish itself on or within 276 
a host and enhance its potential to cause disease. The virulence of a pathogen depends on its 277 
ability to accomplish the different steps required to cause infection: adhesion, colonization, 278 
invasion, immune response inhibition and/or production of toxins. In general, the success of 279 




proliferation and defense mechanisms. With modest virulence machinery, opportunistic 281 
pathogens are commensal or environmental bacteria, often innocuous for a healthy 282 
individual. However, these bacteria, have the potential to cause disease in individuals with 283 
diminished defenses (e.g., disease, wound, medication, prior infection, immunodeficiency, 284 
ageing), due to the presence of virulence factors that facilitate invasion and or proliferation 285 
in the host (Brown et al. 2012). Some of the Betaproteobacteria found in DW have a distinct 286 
array of virulence factors and, therefore, meet the criterion of opportunistic pathogens (Table 287 
1). 288 
Virulence factors or homologous genes have been described in 11 out of the 24 289 
Betaproteobacteria genera detected in both DW (tap and mineral) and in the human 290 
microbiome (Table 1). The fact that only these 11 genera were reported as potential carriers 291 
of virulence factors suggests a major knowledge gap about ubiquitous and potentially 292 
hazardous microbial groups. Curiously, not even for species associated with outbreaks, as 293 
Ralstonia pickettii and R. mannitolilytica, were described virulence factors (Labarca et al. 294 
1999; Maroye et al. 2000; Daxboeck et al. 2005; Gröbner et al. 2007; Coman et al. 2017). 295 
Virulence factors may be divided into membrane proteins, capsule, secretory proteins, and 296 
others (Table 1). The membrane proteins are mainly associated with the increased capacity 297 
of adhesion of the bacteria to the host cells (Wu HJ et al. 2008). Specifically, type IV 298 
secretion systems (T4SS), only described in Gram-negative bacteria and common among 299 
these bacteria, were frequently reported in DW Betaproteobacteria, in six different genera 300 
(Table 1). The presence of a capsule, a key virulence determinant that can mediate resistance 301 
to both phagocytosis and complement-mediated killing (Reckseidler-Zenteno et al. 2005; 302 




include the systems of transport of toxins, the toxins, and immune response inhibitors, as 304 
well as other siderophores or proteins, all of them observed in DW Betaproteobacteria (Table 305 
1). Secretion systems (SS) are used by bacteria to secrete virulence factors from the cytosol 306 
into host cells or the host environment, and can span the inner and outer membrane (e.g. RND 307 
efflux systems, T1SS, T2SS, T3SS, T4SS, T6SS) or only the outer membrane (e.g. T5SS) 308 
(Costa et al. 2015). In human-associated DW Betaproteobacteria, the most common 309 
secretion systems seem to be T2SS, T3SS, and T6SS (Table 1). One of those, the T3SS, also 310 
known as “injectisome”, has an important role in the proteins export from the bacterial 311 
cytoplasm into the host eukaryotic cells (Cornelis 2006; Puhar and Sansonetti 2014), being 312 
the mechanism used by B. pseudomallei to cause melioidosis in mammals or R. 313 
solanacearum to cause plant bacterial wilt (Stevens et al. 2002; Valls et al. 2006; Puhar and 314 
Sansonetti 2014). The multidrug RND (resistance nodulation cell division) efflux pumps, 315 
described for B. pseudomallei (Table 1), may be responsible for intrinsic resistance to several 316 
antimicrobials (Munita and Arias 2016; Rhodes and Schweizer 2016). T4SS, only described 317 
in B. cenocepacia and A. xylosoxidans (Table 1), allow the transport of DNA and may have 318 
an important role in the transfer of genetic material (Cascales and Christie 2003; Green and 319 
Mecsas 2016). Toxin production is described in members of the genera Burkholderia, 320 
Chromobacterium, and Achromobacter (Table 1).  321 
Quorum-sensing (QS) rules a bacterial cell-to-cell communication process, based on auto-322 
inducer signaling, enabling bacteria to adjust the cell density and gene expression, regulating 323 
activities such as bioluminescence, sporulation, competence, antibiotic production, biofilm 324 
formation, or virulence factor secretion (Rutherford and Bassler 2012). QS is important in 325 




2013). These communication processes have been described in Burkholderia spp. and 327 
Chromobacterium violaceum, Ralstonia solanacearum, or Polaromonas spp. (Table 1).  328 
This review on virulence factors reveals that the machinery for host colonization, invasion 329 
and infection, typical of opportunistic pathogens, is available in DW Betaproteobacteria that 330 
can also be associated with the human microbiome. Potential virulence may not be eliminated 331 
by disinfection as was demonstrated by previous studies that showed that chlorination may 332 
promote the increase of the relative abundance of virulence proteins in drinking water (e.g. 333 
translocases, transposons, Clp proteases, and flagellar motor switch proteins) (Huang et al. 334 
2014). Potential virulence combined with disinfection resilience put DW Betaproteobacteria 335 
among the potentially relevant safety biomarkers. 336 
 337 
Antimicrobial resistance in DW Betaproteobacteria  338 
In addition to the ubiquitous character and virulence potential, some Betaproteobacteria 339 
exhibit resistance to different antibiotics (Vaz-Moreira et al. 2014; Khan et al. 2016; Vaz-340 
Moreira et al. 2017), which may increase the risk associated with their presence in DW. Jia 341 
et al. (2015) demonstrated that the relative abundance of antibiotic resistance genes (ARGs) 342 
increased after DW chlorination, being Betaproteobacteria Acidovorax spp. among the 343 
bacterial groups that most contributed to that shift. Also in natural mineral/spring water, not 344 
subjected to any kind of treatment, the presence of Betaproteobacteria yielding antibiotic 345 
resistance phenotypes has been reported (Messi et al. 2005; Falcone-Dias et al. 2012). These 346 




Although most of the antimicrobial resistance mechanisms detected in the environment can 348 
be intrinsic, meaning they are a phenotypic expression of a gene that is common to all 349 
members of a given species or genus, they can still contribute to the failure of antibiotic 350 
therapy (Cox and Wright 2013; Perry et al. 2014). A well-known example of intrinsic 351 
resistance is the presence of the outer membrane (OM) in Gram-negative bacteria that may 352 
modify their porin channels to confer impermeability to different molecules or the presence 353 
of efflux pumps that allow the reduction of the intracellular concentration of a given drug 354 
contributing to multidrug resistance (MDR) phenotype (Cox and Wright 2013; Perry et al. 355 
2014; Pothula et al. 2016). The intrinsic resistance is inherited vertically, from one generation 356 
to the next.  357 
Different intrinsic antimicrobial resistance mechanisms are described in Betaproteobacteria 358 
species, although this information is available for a reduced number of species, specifically 359 
for six out of the 36 genera reported in both tap and bottled mineral water (Table 2). This 360 
information scarcity is also related with the limited attention that has been given to this group 361 
of bacteria, with the exception of a few species that are considered of high clinical relevance 362 
(e.g. Achromobacter xylosoxidans and Burkholderia cepacia). The DW Betaproteobacteria 363 
intrinsic resistance is frequently against penicillins and cephalosporins, as well as to other 364 
antimicrobial agents, as fosfomycin (Table 2). It is important to note that some of the species 365 
related to the bacterial genera commonly found in DW habitats present intrinsic resistance to 366 
some drugs that are considered last-resort drugs, being only used in clinical settings. For 367 
example, the colistin (polymyxin E) is the only clinically approved therapeutic agent that 368 
inhibits the OM and efflux systems (Cox and Wright 2013). However, some Burkholderia 369 




intrinsically resistant to colistin (Table 2), and are also reported as infectious agents 371 
(Patjanasoontorn et al. 1992; Jones et al. 2001; Sirinavin et al. 2005; Yuan et al. 2006; 372 
Kennedy et al. 2007; Yang and Li 2011; Hu C-h and Wang 2012). Also beta-lactams are 373 
frequently used as front-line treatments in combinations antibiotic/beta-lactamase inhibitor 374 
(e.g. sulbactam, clavulanate, tazobactam) (Cox and Wright 2013). However, also to these 375 
combinations were detected intrinsic resistance phenotypes in Achromobacter xylosoxidans 376 
and Burkholderia cepacia (Table 2). Aminoglycosides resistance, described in Burkholderia 377 
spp. or A. xylosoxidans (Table 2), is supposedly intrinsic and may be associated to the 378 
presence of RND multidrug efflux pumps (e.g. BpeAB-OprB, AmrAB-OprA or AxyXY-379 
OprZ) (Buroni et al. 2009; Bador et al. 2013). This is particularly relevant when some studies 380 
show that the occurrence of the RND efflux systems increases in DW after chlorination (Jia 381 
et al. 2015). The association of these efflux systems to an increased tolerance or resistance to 382 
aminoglycosides is curious because previous studies have shown a higher prevalence of 383 
resistance to aminoglycosides after DW treatment (Armstrong et al. 1982; Vaz-Moreira et al. 384 
2011; Vaz-Moreira et al. 2012; Narciso-da-Rocha et al. 2013; Ma et al. 2017). Although 385 
intrinsic resistance has a low potential to be transferred to other bacteria, it may jeopardize 386 
the treatment of infections caused by these bacteria. 387 
In addition, some of the described Betaproteobacteria characteristics may contribute to their 388 
capacity to acquire new resistance to antibiotics, as the capacity to form biofilms and the 389 
presence of type 4 secretion systems (T4SS) (Table 1). While the T4SS allows the transport 390 
of DNA, the biofilm formation allows a close proximity between cells, facilitating both the 391 
dissemination of resistance genes between cells by horizontal gene transfer (HGT) (Cascales 392 




observed that conjugation can be up to 700-fold more efficient in biofilms than in free-living 394 
bacterial cells. Described examples are the A. xylosoxidans acquired resistance to 395 
ciprofloxacin, ceftazidime and carbapenems, in clinical isolates from cystic fibrosis patients 396 
(Amoureux et al. 2013) and the acquisition of new genetic elements associated to mobile 397 
genetic elements (Riccio et al. 2001; Iyobe et al. 2002; Shin et al. 2005; Neuwirth et al. 2006; 398 
El Salabi et al. 2012; Yamamoto et al. 2012; Hu Y et al. 2014), or the Burkholderia spp. 399 
acquired antibiotic resistance to fluoroquinolones, trimethoprim among others (Pitt et al. 400 
1996; Thibault et al. 2004; Rhodes and Schweizer 2016). Apart from these two genera, based 401 
on our literature search, no information is available for possible acquired antibiotic resistance 402 
mechanisms.  403 
Of special interest in Betaproteobacteria, are the processes of co-resistance or cross-404 
resistance. While co-resistance is mainly due to genetic linkage (e.g. antibiotic and metal 405 
resistance in the same genetic element), cross-resistance is due to broad spectrum resistance 406 
mechanisms (e.g. MDR efflux pumps). In both cases,  resistance to the exposure to a specific 407 
agent (e.g. antibiotics, metals, disinfectants) may facilitate the selection of populations 408 
resistant to different antimicrobial agents (Chapman 2003; Baker-Austin et al. 2006).  409 
 410 
Concluding remarks and future research challenges 411 
Water quality is a central issue for human health and wellbeing. On average, an adult ingests 412 
about 1 L of water per day, every day. This makes of water the food product ingested at the 413 
highest amounts during a person lifetime. Simultaneously, water is also an important way of 414 




For these reasons, DW microbiome may play an important role in human health and 416 
wellbeing, with relevant implications of the major populations, such as Betaproteobacteria. 417 
While some DW bacteria may be beneficial or innocuous, others may represent a risk for 418 
human health. The latter may be due to some DW Betaproteobacteria.  419 
Betaproteobacteria are abundant and diverse in DW or DW biofilms, being some of them 420 
ubiquitous to tap and bottled natural mineral/spring water (Figure 1). Moreover, some DW 421 
Betaproteobacteria are also reported in humans. The human health risk posed by DW 422 
Betaproteobacteria can be inferred from their resistance to disinfection, the presence of 423 
virulence factors and intrinsic antibiotic resistance. Some of the virulence factors described 424 
in Betaproteobacteria, such as adherence factors or the capacity to form biofilms, may 425 
contribute to explain the ability of these bacteria to survive in water habitats. Hypothetically, 426 
all these are factors that may increase the probability of causing opportunistic infections, 427 
being here highlighted in the need for further research in this field.  428 
From this literature review, three bacteria genera seem to stood out: Achromobacter, 429 
Burkholderia, and Ralstonia. Members of these genera were also those previously associated 430 
with infection outbreaks. Given the phylogenetic and physiologic proximity, other 431 
Betaproteobacteria genera might share similar properties still unknown, given the scarcity 432 
of information. This was, indeed, a major conclusion of this review. Bacteria that are not 433 
considered primary pathogens are, most of the times, not screened in routine monitoring 434 
analyses in clinical situations. For example, Ralstonia spp. occasionally associated with 435 
infection episodes, may be a misidentified opportunistic pathogen, if it is not included in the 436 
screened pathogen database (Daxboeck et al. 2005; Ryan et al. 2006; Ryan and Adley 2014; 437 




The first step to improve the current knowledge is to have a good overview of the 439 
Betaproteobacteria diversity in DW and their possible association with humans, virulence, 440 
adaption potential, and genome dynamics for antimicrobial resistance or virulence 441 
acquisition. This review is a first step to fill in this gap. Because some of those characteristics 442 
will be better understood based on culture methods, additional investment in culturomic 443 
approaches are most welcome in the DW microbiology field (Greub 2012; Lagier et al. 2012).  444 
Although DW is considered important for human health and well-being, many questions are 445 
still requiring our attention. It is important to understand how/if the DW microbiota, 446 
including the Betaproteobacteria group, focused in this review, may direct or indirectly 447 
influence human health.  448 
 449 
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Table 1. Described virulence factors or homologous genes (*) in Betaproteobacteria genera observed in tap and bottled mineral 1110 
drinking water and described as human-associated bacteria 1111 
Classification Sub-classification Examples Drinking-water associated bacteria References 
Membrane 
proteins 
Adhesion Burkholderia oligomeric coiled-coil adhesin A 
(BoaA) and b (BoaB). 
Burkholderia pseudomallei (Balder et al. 2010) 
  
Pilus structural proteins (Type IV pili) B. pseudomallei; Burkholderia 
cenocepacia; Acidovorax avenae subsp. 
avenae; Acidovorax citrulli; Ralstonia 
solanacearum; Limnobacter thiooxidans 
(*); Chromobacterium violaceum (*) 
(Liu et al. 2001; Kang et al. 2002; 
Alves de Brito et al. 2004; Essex-
Lopresti et al. 2005; Bahar et al. 2009; 
Holden M. T. et al. 2009; Burdman 
and Walcott 2012; Ibrahim et al. 2012; 
Stone et al. 2014; Har et al. 2015)   
Chaperone-usher type fimbriae B. cenocepacia (Holden M. T. et al. 2009)   
Flp-type pili B. cenocepacia; Cupriavidus taiwanensis 
(*) 
(Amadou et al. 2008; Holden M. T. et 
al. 2009) 
  
Hemagglutinin/hemolysin related B. pseudomallei (*); L. thiooxidans (*); 
Achromobacter xylosoxidans (*) 
(Dowling et al. 2010; Li et al. 2013; 
Har et al. 2015)   
Mannose-fucose binding lectin (LecM) R. solanacearum (Meng et al. 2015) 
  
22-Kda adhesion protein AdhA B. cenocepacia (Holden M. T. et al. 2009) 
  
BuHA family of proteins B. cenocepacia (Holden M. T. et al. 2009) 
 
  BcaA autotransporter protein B. pseudomallei (Campos et al. 2013; Stone et al. 
2014) 
  poly-β-1,6-N-acetyl-D-glucosamin (pga 
operon) 
A. xylosoxidans (*) (Jakobsen et al. 2013) 




Burkholderia intracellular motility A (BimA) B. pseudomallei, Burkholderia mallei; 
Burkholderia thailandensis 
(Stevens et al. 2005; Sitthidet et al. 




Polar flagella B. pseudomallei; B. cenocepacia; A. 
citrulli 
(Chua et al. 2003; Inglis et al. 2003; 
Urban et al. 2004; Burdman and 
Walcott 2012) 
 
  BuHA family of autotransporting membrane 
proteins 





Surface components LPS core oligosaccharide B. cenocepacia; A. xylosoxidans (*); C. 
violaceum (*) 
(Alves de Brito et al. 2004; Loutet and 
Valvano 2010; Li et al. 2013)  
  EPS (extracellular polysaccharide) R. solanacearum (Genin and Denny 2012) 
 
Others HtrA protease B. cenocepacia (Flannagan et al. 2007) 
    cbb3-Type Cytochrome c Oxidase R. solanacearum (Colburn-Clifford and Allen 2010) 
Capsule Antiphagocytosis Type I O-polysaccaharide (capsule I) B. pseudomallei (DeShazer et al. 1998; Reckseidler-
Zenteno et al. 2005; Wikraiphat et al. 
2009) 
  
Cepacian polysaccharide B. cenocepacia (Holden M. T. et al. 2009) 
    Capsular polysaccharides (CPS)  B. pseudomallei, B. thailandensis (Reckseidler-Zenteno et al. 2005; 






Mip-like (macrophage infectivity potentiator) C. taiwanensis (*) (Amadou et al. 2008) 
  
Proteases B. pseudomallei (*) (Dowling et al. 2010) 
  
Phospholipases B. pseudomallei (*) (Dowling et al. 2010) 
 
  TssM (BPSS1512) deubiquitinase B. pseudomallei (Tan et al. 2010) 
 
Toxins HicA toxin B. pseudomallei (Butt et al. 2014) 
  
Bcc toxin Burkholderia cepacia complex (Thomson and Dennis 2012) 
  
Burkholderia Lethal Factor 1 (BLF1) B. pseudomallei (Cruz-Migoni et al. 2011) 
 
  Hemolysin B. cepacia; B. pseudomallei (*); C. 
violaceum (*) 
(Hutchison et al. 1998; Alves de Brito 
et al. 2004; Dowling et al. 2010) 
  RTX toxin A. xylosoxidans (*) (Li et al. 2013) 
  Colicin V and exoenzyme regulatory protein 
(AepA) 
A. xylosoxidans (*); C. violaceum (*) (Alves de Brito et al. 2004; Jakobsen 
et al. 2013)  
Transport of toxins RND efflux pump (e.g. BpeAB-OprB) B. pseudomallei (Chan and Chua 2005; Mima and 
Schweizer 2010) 
  Type I secretion system (T1SS) B. pseudomallei; B. cenocepacia; C. 
violaceum (*) 
(Alves de Brito et al. 2004; Holden 
Matthew TG et al. 2004; Holden M. T. 





Type II secretion system (T2SS) B. pseudomallei; B. mallei; B. 
cenocepacia; R. solanacearum; A. avenae 
subsp. avenae (*); A. citrulli (*); C. 
taiwanensis (*); L. thiooxidans (*); C. 
violaceum (*); A. xylosoxidans (*) 
(Holden Matthew TG et al. 2004; 
Amadou et al. 2008; Holden M. T. et 
al. 2009; Persson et al. 2009; 
Poueymiro and Genin 2009; Burdman 
and Walcott 2012; Ibrahim et al. 2012; 
Har et al. 2015)   
Type III secretion system (e.g. Bsa T3SS) B. pseudomallei; B. mallei; B. 
thailandensis; B. cenocepacia; R. 
solanacearum; A. citrulli; Herbaspirillum 
rubrisubalbicans; A. avenae subsp. 
avenae (*); C. taiwanensis (*); 
Limnobacter sp. (*); C. violaceum (*); A. 
xylosoxidans (*) 
(Stevens et al. 2003; Alves de Brito et 
al. 2004; Holden Matthew TG et al. 
2004; Genin et al. 2005; Amadou et 
al. 2008; Cullinane et al. 2008; 
Whitlock et al. 2008; Holden M. T. et 
al. 2009; Poueymiro and Genin 2009; 
Muangman et al. 2011; Ibrahim et al. 
2012; Schmidt et al. 2012; Jakobsen et 
al. 2013; Li et al. 2013; Kondo et al. 
2017)   
Type IV secretion system (T4SS) B. cenocepacia; A. xylosoxidans (*) (Engledow et al. 2004; Li et al. 2013) 
  
Type V secretion system (T5SS) B. pseudomallei; B. mallei; B. 
cenocepacia; Limnobacter sp. (*) 
(Holden Matthew TG et al. 2004; 
Holden M. T. et al. 2009; Persson et 
al. 2009)  
  Type VI secretion system (e.g. T6SS-5) B. pseudomallei; B. mallei; B. 
cenocepacia; B. thailandensis; A. avenae 
subsp. avenae; A. citrulli; C. taiwanensis 
(*); L. thiooxidans (*); Limnobacter sp. 
(*); A. xylosoxidans (*) 
(Amadou et al. 2008; Schell et al. 
2008; Holden M. T. et al. 2009; 
Persson et al. 2009; Schwarz et al. 
2010; Ibrahim et al. 2012; Jakobsen et 
al. 2013; Burtnick et al. 2014; Har et 
al. 2015; Tian et al. 2015) 
 
Other Zinc metalloproteases ZmpA and ZmpB B. cenocepacia (Holden M. T. et al. 2009)   
Phospholipases C B. cenocepacia (Holden M. T. et al. 2009) 
  
Siderophores (e.g. ornibactin, salicylic acid, 
pyochelin, staphyloferrin B, micacocidin) 
B. cenocepacia; R. solanacearum; L. 
thiooxidans (*) 
(Sokol et al. 1999; Bhatt and Denny 
2004; Holden M. T. et al. 2009; 
Kreutzer et al. 2011; Har et al. 2015)   
bipB, bipC and bipD proteins B. pseudomallei (Stone et al. 2014; Vander Broek and 
Stevens 2017) 
  





MprA serine metalloprotease B. pseudomallei (Valade et al. 2004; Burtnick et al. 
2014) 
    MgtC protein B. cenocepacia (Rang et al. 2007) 
Others Biofilm production FixLJ system B. cepacia complex (Schaefers et al. 2017) 
  
Lys-R type regulator B. cenocepacia; R. solanacearum (Brumbley et al. 1993; Schell 2000; 
Bernier et al. 2008) 
 




  B. cenocepacia (Law et al. 2008) 
 Denitrification Nitrate reduction (e.g. Nos system, NirV) A. xylosoxidans (*) (Jakobsen et al. 2013) 
 
Signalling c-di-GMP-specific phosphodiesterase (CdpA)  B. pseudomallei (Lee HS et al. 2010) 
  
CepIR Quorum-sensing system most Burkholderia spp. (Lewenza et al. 1999; Ulrich et al. 
2004; Chan and Chua 2005; Song et 
al. 2005; Subsin et al. 2007; Holden 
M. T. et al. 2009; Subramoni and 
Sokol 2012)   
CciIR Quorum-sensing system B. cenocepacia (Baldwin et al. 2004) 
  
BDSF, nonhomoserine lactone signal molecule B. cenocepacia (Boon et al. 2008) 
  
BviIR Quorum-sensing system B. vietnamiensis (Malott and Sokol 2007) 
  
PmlI-PmlR Quorum-Sensing System B. pseudomallei (Valade et al. 2004) 
  Violacein (CviI/R AHL QS system) C. violaceum (Steindler and Venturi 2007)  
  other Quorum sensing systems A. citrulli; R. solanacearum; 
Polaromonas spp. (*) 
(Spirig et al. 2008; Johnson and 
Walcott 2013; Meng et al. 2015; 





Table 2. Described intrinsic antimicrobial resistance in Betaproteobacteria species belonging to bacterial genera detected in both tap 1113 



















Ertapenem Aztreonam + n.i. n.i. n.i. n.i. Trimethoprim, 
Fosfomycin 
(Almuzara et al. 
2010; Bador et 
al. 2013; 
Leclercq et al. 































(Baxter et al. 
1997; Palleroni 
2005; Leclercq et 
al. 2013; Abbott 
and Peleg 2015; 











Ticarcillin n.i. n.i. n.i. n.i. n.i. Norfloxacin n.i. n.i. Fosfomycin, 
Clindamycin 




Ticarcillin Cefoxitin n.i. n.i. Gentamicin, 
Streptomycin, 
Erythromycin 
n.i. Norfloxacin n.i. n.i. Fosfomycin, 
Clindamycin 
(Thibault et al. 
2004; Buroni et 





Cephaloridine n.i. n.i. n.i. Colistin n.i. Sulfafurazole n.i. Vibriostatic 
agent O/129 
(Gillis and Logan 
2005a)  
Herbaspirillum 
seropedicae and H. 
rubrisubalbicans 
Pennicilin n.i. n.i. n.i. n.i. n.i. Nalidixic 
acid 
n.i. n.i. Novobiocin, 
Rifampicin 




Pennicilin n.i. n.i. n.i. n.i. n.i. n.i. n.i. n.i. Vancomycin (Lincoln et al. 
1999; Gillis and 






Pennicilin n.i. n.i. n.i. n.i. Colistin n.i. n.i. n.i. Nitrofurantoin, 
Vibriostatic 
agent O/129 






n.i. n.i. n.i. n.i. n.i. n.i. n.i. n.i. Novobiocin (Willems et al. 
2005) 
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Figure 1. Diversity of Betaproteobacteria in drinking water habitats and in the Human microbiome. The black symbol means 1117 
“detected”, the white “non-detected”. The dendrogram was constructed with the iTOL – interactive tree of life (Letunic and Bork 1118 
2016), based on the taxon ID codes. 1119 
